06-19 Induct Plans Up to NOK20 Million Capital Raise Via Underwritten Rights Issue MT
06-15 Induct : Invitation to company presentation PU
05-28 Induct : Annual Report 2025 – Events after the balance sheet date PU
05-13 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-16 Induct : Finansiell kalender PU
02-12 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-13 Induct AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-10-20 Induct notifies regulator of possible market abuse violations RE
25-09-22 Induct : Meldepliktig handel for primærinnsider – Styremedlem og største aksjonær øker eierandelen PU
25-08-14 Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-14 Induct Q2 Ebitda Nok 3.3 Mln RE
25-08-14 Induct : Interim Report Q2 2025 PU
25-07-18 Induct CFO steps down RE
25-07-07 Induct Raises NOK6 Million in Private Placement to Reduce Debt MT
25-07-07 Induct completes private placement RE
25-05-27 Induct, Norne Securities Enter Into Market Making Agreement RE
25-05-23 Induct: Astrazeneca Starts Commercial Discussions Earlier Than Planned RE
25-05-23 Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned AQ
25-04-23 Management Software Developer Induct Raises NOK14.5 Million from Share Sale MT
25-04-10 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-10 Induct Q1 EBITDA Rises To NOK 3.0 Mln RE
25-03-05 Induct Says Hittabidrag Signs Its First Municipal Agreement RE
25-02-13 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-11-14 Induct AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-22 Induct : Update; Induct strengthens its leadership team with new CTO – Ignacio Orteu Giménez PU
No results match your criteria
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!